MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2020

    Association of Interleukin (IL)-2 and IL2RA gene polymorphisms with Parkinson’s disease in Taiwan

    T. Liu, Y. Wu, Y. Chen, H. Fung, C. Chen (Taoyuan, Taiwan)

    Objective: The purpose of this study is to investigate if interleukin 2 (IL-2) and interleukin 2 receptor alpha (IL2RA) genes are associated with Parkinson’s disease…
  • MDS Virtual Congress 2020

    LIPAD (LRRK2/Luebeck) International Parkinson’s Disease Study: Detecting genetic and environmental modifiers of penetrance and disease expression

    T. Usnich, N. Schell, E.J Vollstedt, V. Skrahina, X. Bogdanovic, N. Koleva-Alazeh, I. Csoti, T. Förster, A. Heuer, N. Brüggemann, P. Bauer, M. Kasten, A. Rolfs, C. Klein (Luebeck, Germany)

    Objective: The international multicenter LIPAD study is a deep-phenotyping, follow-up study to ROPAD (Rostock Parkinson’s Disease Study) with the aim to systematically characterize Parkinson's disease…
  • MDS Virtual Congress 2020

    Mass spectrometry-based proteomics brain analysis to distinguish between Parkinson syndromes

    A. Rajput, P. Chumala, B. Thompson, A. Rajput, G. Katselis (Saskatoon, SK, Canada)

    Objective: To address the gap existing during clinical diagnosis in differentiating among various forms of Parkinson syndrome (PS) by using mass spectrometry (MS)-based brain proteomics.…
  • MDS Virtual Congress 2020

    Exploring dopamine transporter single-photon emission computed tomography quantification as a measure of disease progression in idiopathic Parkinson’s disease

    J. Gurwell, R. El Khouli, G. Quintero, J. Slevin, M. Yazell, C. van Horne (Lexington, KY, USA)

    Objective: To evaluate the ability of DAT SPECT quantification to track disease progression in subjects with idiopathic Parkinson's disease (PD) by comparing baseline scans to…
  • MDS Virtual Congress 2020

    Frailty as clinical modulator of brain damage and progression in Parkinson’s disease

    A. Pilotto, A. Lupini, F. Savoldi, F. Conforti, G. Giannì, A. Imarisio, S. Gipponi, E. Cottini, A. Scalvini, S. Masciocchi, S. Nocivelli, R. Grasso, R. Turrone, M. Rizzetti, A. Padovani (Brescia, Italy)

    Objective: To evaluate the prevalence of frailty and correlation with motor and non-motor symptoms as well as MRI atrophy and white matter hyperintensities in Parkinson's…
  • MDS Virtual Congress 2020

    Utilization of a Visualization Software Tool for Deep Brain Stimulation Programming in a Subset of Subjects with Parkinson’s Disease Who Participated in the INTREPID Randomized Clinical Trial

    M. Tagliati, L. Chen, R. Jain (Los Angeles, CA, USA)

    Objective: This report will describe the utilization and parameters associated with the use of a new visualization tool for Deep Brain Stimulation (DBS) programming in…
  • MDS Virtual Congress 2020

    Application of Deep Neuronal Networks for the extraction of spectral characteristics in patients with Parkinson’s disease

    A. Maitin, A. Garcia-Tejedor, M. Castillo, I. Serrano, E. Rocon, A. Arroyo, J. Andreo, J. Romero (Pozuelo de Alarcon, Spain)

    Objective: We analyze and compare the spectral bands of electroencephalograms (EEGs) associated to motor activation for both patients with Parkinson's disease (PD) and healthy patients…
  • MDS Virtual Congress 2020

    Sexual Dysfunction Among Patients with Parkinson’s Disease in Dakar Senegal

    H.D Ewodo, M. Traore, B.G Ekanmian, C.G De Chacus, K. Toure (Dakar, Senegal)

    Objective: The aim of this study was to describe the sexual disorder in patients that have Parkinson’s disease at Fann University Hospital in Dakar, Senegal.…
  • MDS Virtual Congress 2020

    Parkinson’s Disease patients with diplopia exhibit visuospatial and visuoperceptive impairment

    W. Naumann, J. Gogarten, S. Schoenfeld, F. Klostermann, F. Marzinzik, K. Schindlbeck (Berlin, Germany)

    Objective: In this study, we investigated Parkinson’s disease (PD) patients with and without diplopia using motor and non-motor assessments, including detailed neuropsychological testing. We hypothesized…
  • MDS Virtual Congress 2020

    Is Chronotype a biomarker for depression in military Veterans with Parkinson’s disease?

    A. Sarwar (Houston, TX, TX, USA)

    Objective: To determine the association of different chronotypes with depression in military Veterans with Parkinson's disease (PD). Background: Depression is a common non-motor symptom in…
  • « Previous Page
  • 1
  • …
  • 126
  • 127
  • 128
  • 129
  • 130
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley